Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) – Stock analysts at William Blair lowered their Q2 2022 earnings per share estimates for Option Care Health in a research note issued to investors on Thursday, April 28th. William Blair analyst M. Larew now expects that the company will earn $0.27 per share for the quarter, down from their prior forecast of $0.37.
Several other research analysts also recently commented on OPCH. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Option Care Health from $32.00 to $39.00 in a report on Friday. Barrington Research raised their price target on shares of Option Care Health from $31.00 to $33.00 in a research report on Friday. Zacks Investment Research upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and set a $31.00 target price on the stock in a research report on Tuesday, April 26th. Finally, TheStreet lowered shares of Option Care Health from a “b” rating to a “c+” rating in a research report on Thursday. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Option Care Health presently has an average rating of “Buy” and a consensus target price of $31.17.
Option Care Health (NASDAQ:OPCH – Get Rating) last released its earnings results on Thursday, April 28th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Option Care Health had a net margin of 4.81% and a return on equity of 12.85%. The company had revenue of $915.78 million during the quarter, compared to the consensus estimate of $839.45 million. During the same quarter in the prior year, the firm earned ($0.02) EPS. The company’s revenue was up 20.6% compared to the same quarter last year.
A number of hedge funds and other institutional investors have recently bought and sold shares of OPCH. Morgan Stanley raised its position in shares of Option Care Health by 63.6% in the second quarter. Morgan Stanley now owns 202,717 shares of the company’s stock valued at $4,434,000 after purchasing an additional 78,818 shares during the period. SG Americas Securities LLC grew its stake in Option Care Health by 4.1% during the third quarter. SG Americas Securities LLC now owns 20,124 shares of the company’s stock worth $488,000 after buying an additional 791 shares in the last quarter. Victory Capital Management Inc. grew its stake in Option Care Health by 100.9% during the third quarter. Victory Capital Management Inc. now owns 30,169 shares of the company’s stock worth $732,000 after buying an additional 15,151 shares in the last quarter. Raymond James & Associates acquired a new stake in Option Care Health during the third quarter worth about $248,000. Finally, Retirement Systems of Alabama acquired a new stake in shares of Option Care Health in the 3rd quarter valued at approximately $4,386,000. 97.80% of the stock is currently owned by hedge funds and other institutional investors.
In other news, COO Harriet Booker sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, March 7th. The shares were sold at an average price of $26.12, for a total value of $156,720.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have sold 18,000 shares of company stock valued at $461,460. Corporate insiders own 47.00% of the company’s stock.
About Option Care Health (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.